Children Oncology Group, USA Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2011
NCT01516580
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leukemia (Phase 3)

Leukemia, B-Cell (Phase 3)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)

Lymphoma (Phase 3)

Lymphoma, B-Cell (Phase 3)

Lymphoma, Non-Hodgkin (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 6